These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37749430)
1. Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway. Liu Y; Chen H; Xiao L; Dong P; Ma Y; Zhou Y; Yang J; Bian B; Xie G; Chen L; Shen L Cell Oncol (Dordr); 2024 Apr; 47(2):463-480. PubMed ID: 37749430 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway. Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582 [TBL] [Abstract][Full Text] [Related]
3. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635 [TBL] [Abstract][Full Text] [Related]
4. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738 [TBL] [Abstract][Full Text] [Related]
5. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway. Zhang H; Zhang L; Lu M Bioengineered; 2021 Dec; 12(2):11909-11921. PubMed ID: 34802381 [TBL] [Abstract][Full Text] [Related]
7. RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4/PI3K/AKT signaling. Xun J; Ma Y; Wang B; Jiang X; Liu B; Gao R; Zhai Q; Cheng R; Wu X; Wu Y; Zhang Q Acta Histochem; 2024 Oct; 126(5-7):152190. PubMed ID: 39173233 [TBL] [Abstract][Full Text] [Related]
8. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway. Li J; Zhang X; Liu X; Ma X; Wang Y; Liu Y Expert Rev Anticancer Ther; 2024 Oct; 24(10):1029-1040. PubMed ID: 39254227 [TBL] [Abstract][Full Text] [Related]
9. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism. Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157 [TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957 [TBL] [Abstract][Full Text] [Related]
11. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling. Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885 [TBL] [Abstract][Full Text] [Related]
12. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer. Li Q; Ge Y; Chen X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z J Cell Biochem; 2019 Sep; 120(9):15190-15201. PubMed ID: 31021450 [TBL] [Abstract][Full Text] [Related]
13. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway. Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034 [TBL] [Abstract][Full Text] [Related]
14. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway. Cheng L; Li X; Dong W; Yang J; Li P; Qiang X; Yin J; Guo L J Cancer Res Clin Oncol; 2024 May; 150(5):230. PubMed ID: 38703300 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [TBL] [Abstract][Full Text] [Related]
16. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer. Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520 [TBL] [Abstract][Full Text] [Related]
17. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression. Zhao H; Jiang R; Feng Z; Wang X; Zhang C J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488 [TBL] [Abstract][Full Text] [Related]
18. Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway. Lin M; Tu RH; Wu SZ; Zhong Q; Weng K; Wu YK; Lin GT; Wang JB; Zheng CH; Xie JW; Lin JX; Chen QY; Huang CM; Cao LL; Li P Cell Death Dis; 2024 Jul; 15(7):497. PubMed ID: 38997271 [TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766 [TBL] [Abstract][Full Text] [Related]
20. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway. Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]